Primary Record
Ulipristal acetate
- In stock
- 8,451 g
- Purity
- 99.8 %
- CAS
- 126784-99-4
Compound Identifiers & Properties
- CAS
- 126784-99-4
- PubChem CID
- 130904
- SMILES
- CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C
- Canonical SMILES
- CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
Names & Synonyms
- Ulipristal acetate
- Ulipristal
- Ella
- EllaOne
- 126784-99-4
- Esmya
- Ulipristal acet
- Ulipristal?
- Ulipristal Actate
- 4oar
- Ulipristal-Acetate
- EllaOne|||Esmya
- Ella norpregnadiene
- CDB-2914
- LOGILIA
- Ulipristal (acetate)
- Ulipristal acetate [USAN]
- Ella (TN)
- RefChem:56802
- Hrp-2000
- Ulipristal acetate(CDB2914)
- UNII-YF7V70N02B
- YF7V70N02B
- 2-aminobutane-1,3-diol
- MFCD00899035
- VA2914
- CDB 2914
- HRP 2000
- AC1L2Y8A
- C17 Epi Ulipristal Acetate
- C30H37NO4
- CHEBI:71025
- PGL-4001
- 3-heptoxybenzenecarboximidamide
- SCHEMBL544957
- Ulipristal acetate (Standard)
- DTXSID30155294
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N
- CHEMBL260538
- GTPL7460
- orb1305355
- ULIPRISTAL ACETATE [MI]
- CBD 2914
- DTXCID9077785
- RTI-3021-012
- Ulipristal acetate (JAN/USAN)
- ULIPRISTAL ACETATE [JAN]
- VA-2914
- ta[a]phenanthren-17-yl] acetate
- ULIPRISTAL ACETATE [VANDF]
- ULIPRISTAL ACETATE [MART.]
- AMX10180
- ULIPRISTAL ACETATE [WHO-DD]
- VA 2914
- ZINC3920657
- BDBM50375424
- C30-H37-N-O4
- CID130904
- EBC-07665
- HY-16508R
- RTI 3021-012
- RU 44675
- Ulipristal acetate, >=98% (HPLC)
- AKOS026750526
- ACN-037304
- CCG-269500
- CS-1157
- CS-O-10778
- KS-00000Z24
- ULIPRISTAL ACETATE [ORANGE BOOK]
- NCGC00378913-02
- AS-73950
- BU161520
- HY-16508
- SC-44720
- SY028095
- (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
- J533.262A
- (11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
- NS00002655
- U0102
- X4788
- RU-3021-012
- 17-Acetoxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione
- C72119
- D09687
- EN300-220766
- W-5201
- AB01566874_01
- 784A994
- A848252
- Q975059
- BRD-K64381438-001-03-8
- Z2185283535
- (11beta)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
- B0084-474444
- (1R,3aS,3bS,10R,11aS)-1-acetyl-10-[4-(dimethylamino)phenyl]-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate
- [(8s,11r,13s,14s,17r)-17-Acetyl-11-[4-(Dimethylamino)phenyl]-13-Methyl-3-Oxo-1,2,6,7,8,11,12,14,15,16-Decahydrocyclopenta[a]phenanthren-17-Yl] Acetate
- (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
- (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate
- 17-alpha-acetoxy-11-beta-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione
- 17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl acetate
- [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
- (11-beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
- (11|_)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
- (11|A)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
- (17R)-11beta-[4-(Dimethylamino)phenyl]-17-acetoxy-19-norpregna-4,9-diene-3,20-dione
- 11-beta-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
- 11beta-[4-(Dimethylamino)phenyl]-17-(acetyloxy)-19-norpregna-4,9-diene-3,20-dione
- 11beta-[4-(Dimethylamino)phenyl]-17alpha-acetoxy-19-norpregna-4,9-diene-3,20-dione
- 11beta-[4-(Dimethylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate
- 17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
- 17beta-acetyl-11beta-(4-(dimethylamino)phenyl)-3-oxoestra-4,9-dien-17alpha-yl acetate
- 17beta-Acetyl-17-acetoxy-11beta-[4-(dimethylamino)phenyl]estra-4,9-diene-3-one
- 19-Norpregna-4,9-diene-3,20-dione,17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11b)-
- 5-(Hydroxymethyl)-alpha,alpha,alpha,alpha-tetramethyl-1,3-benzenediacetonitrile
- ((8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-17-yl) acetate
- (11.BETA.)-17-(ACETYLOXY)-11-(4-(DIMETHYLAMINO)PHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE
- (11alpha,13alpha,17beta)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate
- (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylacetate
- (8S,11R,13S,14S,17R)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl Acetate
- [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-16-methylidene-3,6-dioxo-2,7,8,9,11,12,14,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
- [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopen
- 120511-88-8
- 159811-51-5
- 17.ALPHA.-ACETOXY-11.BETA.-(4-DIMETHYLAMINOPHENYL)-19-NORPREGNA-4,9-DIEN-3,20-DIONE
- 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-
- 31065-03-9
- 31066-04-3
- 31066-40-7
- C17 Isomer Ulipristal Acetate; (10S,11S,14S,15S,17R)-14-Acetyl-17-[p-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-1,6-dien-14-yl acetate
- CBD 2914; VA 2914; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione